Xgenera
PrivateLast Round
Seed
Dec 3, 2024
Total Funding Raised
$7.75M
Company Overview
Xgenera is a biotechnology company that develops multi-cancer early detection (MCED) diagnostic tests using microRNA biomarkers and machine learning.
Sector
Enterprise Software
Verticals
Cloud Infrastructure, DevOps & Containers
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xgenera Comparables
Compare Xgenera with similar companies based on industry and business-model similarity.
Xgenera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 3, 2024 | ||||
| Grant | Sep 1, 2024 |
Xgenera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascension Ventures | Seed |
| QantX | Seed |
| Empirical Ventures | Seed |
| National Institute for Health and Care Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 10, 2025
Grew 100% QoQ, from 4 to 8 employees.
- Dec 3, 2024
$4.4M round led by QantX
Xgenera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xgenera's valuation, stock price, and market status.